Clinical Trials Directory

Trials / Unknown

UnknownNCT05956769

Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty

Comparison of TEG-guided and Preemptive Tranexamic Acid Administration Strategies in Total Hip Replacement Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Konkuk University Medical Center · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The present study is a multi-center randomized prospective placebo-controlled non-inferiority trial. The study's primary objective is to compare the amounts of postoperative bleeding using two different TXA administration strategies: empirical TXA administration vs. viscoelastic test-based Goal-directed vs Preemptive Tranexamic Acid Administration in total hip arthroplasty. The secondary objectives include comparing the incidents of hyper-fibrinolysis, thromboembolic complications, and postoperative seizures. Researchers assumed that goal-directed tranexamic acid (TXA) administration using viscoelastic field tests would not be inferior to the empirical TXA administration strategy in reducing postoperative bleeding and hyper-fibrinolysis. It also would be beneficial in lowering TXA-induced thromboembolic complications and seizures.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic AcidTranexamic acid injection 10 mg/kg and infusion 2 mg/kg/hr
DIAGNOSTIC_TESTthromboelastographythromboelastography (TEG6)
DRUGPlaceboNormal saline injection

Timeline

Start date
2024-02-01
Primary completion
2024-11-30
Completion
2024-12-31
First posted
2023-07-21
Last updated
2024-01-02

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05956769. Inclusion in this directory is not an endorsement.